Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RIZWAN DANISH

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1720076284
CMS profile
168910
Location
FLINT, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$7,804.76

311 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $5,930.71 296
Long term medical supply or device loan $1,049.07 12
Consulting Fee $650.00 1
Education $174.98 2

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Novartis Pharmaceuticals Corporation $1,439.12 35
BeiGene USA, Inc. $751.54 5
Genentech USA, Inc. $426.02 22
Janssen Biotech, Inc. $345.57 20
AstraZeneca Pharmaceuticals LP $340.27 13
Astellas Pharma US Inc $299.54 13
PFIZER INC. $289.59 18
Merck Sharp & Dohme LLC $288.38 12
Eisai Inc. $254.04 12
Tempus AI, Inc $191.35 8
Regeneron Healthcare Solutions, Inc. $174.34 5
Takeda Pharmaceuticals U.S.A., Inc. $169.33 7
Incyte Corporation $166.91 11
GlaxoSmithKline, LLC. $160.82 9
GENZYME CORPORATION $152.05 6
Daiichi Sankyo Inc. $105.48 5
E.R. Squibb & Sons, L.L.C. $100.47 6
Legend Biotech USA Inc. $92.10 3
Celgene Corporation $91.30 5
Ipsen Biopharmaceuticals, Inc $90.41 4
Lilly USA, LLC $90.24 5
Acrotech Biopharma Inc. $82.25 4
PharmaEssentia USA Corporation $81.07 4
ARRAY BIOPHARMA INC $79.50 5
ABBVIE INC. $78.41 3
SOBI, INC $77.81 4
Gilead Sciences, Inc. $73.26 4
TAIHO ONCOLOGY, INC. $71.63 3
JAZZ PHARMACEUTICALS INC. $70.37 3
Apellis Pharmaceuticals, Inc. $70.12 4
Alexion Pharmaceuticals, Inc. $69.35 3
EMD Serono, Inc. $61.31 3
Deciphera Pharmaceuticals Inc. $57.59 3
Aveo Pharmaceuticals, Inc. $57.53 3
Rigel Pharmaceuticals, Inc. $56.23 3
SERVIER PHARMACEUTICALS LLC $55.69 3
Exelixis Inc. $52.58 3
Octapharma USA, Inc. $50.06 2
Genmab U.S., Inc. $50.01 2
Mirati Therapeutics, Inc. $45.64 2
Pharmacosmos Therapeutics Inc. $43.82 2
Bayer Healthcare Pharmaceuticals Inc. $37.45 2
Stemline Therapeutics Inc. $37.00 2
Agios Pharmaceuticals, Inc. $34.01 1
Azurity Pharmaceuticals, Inc. $33.08 2
Boehringer Ingelheim Pharmaceuticals, Inc. $31.56 1
Karyopharm Therapeutics Inc. $31.07 1
SUN PHARMACEUTICAL INDUSTRIES INC. $31.07 1
Blueprint Medicines Corporation $28.37 1
Coherus Biosciences Inc. $26.53 1
ACCORD HEALTHCARE, INC. $21.94 1
Dendreon Pharmaceuticals LLC $20.89 1
Janssen Scientific Affairs, LLC $19.53 1
Amneal Pharmaceuticals LLC $19.28 1
SpringWorks Therapeutics, Inc. $18.70 1
TerSera Therapeutics LLC $18.08 1
Fresenius Kabi USA, LLC $17.76 1
Kite Pharma, Inc. $15.64 1
Sumitomo Pharma America, Inc. $15.48 1
PUMA BIOTECHNOLOGY, INC. $15.38 1
Biocon Biologics Inc $14.45 1
Collegium Pharmaceutical, Inc. $14.39 1

Page 3 of 7; records 101–150 of 311 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RIZWAN DANISH

NPI 1720076284 · CMS profile ID 168910

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

FLINT, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 7; records 101–150 of 311 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1720076284?year=2024&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RIZWAN DANISH, NPI 1720076284, CMS profile ID 168910. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 7; records 101–150 of 311 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1720076284?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). RIZWAN DANISH, NPI 1720076284, CMS profile ID 168910. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 7; records 101–150 of 311 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1720076284?year=2024&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
RIZWAN DANISH, NPI 1720076284, CMS profile ID 168910, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 7; records 101–150 of 311 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1720076284?year=2024&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

311 matching records · $7,804.76 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 311 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 311.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Biotech, Inc. $23.1509/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078745619 CMS
Karyopharm Therapeutics Inc. $31.0709/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145536007 CMS
BeiGene USA, Inc. $21.9609/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120858737 CMS
GENZYME CORPORATION $28.4309/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139632575 CMS
PFIZER INC. $14.6309/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131360717 CMS
Daiichi Sankyo Inc. $20.5208/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1089413074 CMS
Merck Sharp & Dohme LLC $29.0008/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141895571 CMS
Octapharma USA, Inc. $25.0908/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142313634 CMS
Gilead Sciences, Inc. $18.9808/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133800158 CMS
Fresenius Kabi USA, LLC $17.7608/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1146945693 CMS
Merck Sharp & Dohme LLC $22.1908/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141778221 CMS
Celgene Corporation $15.9008/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101174794 CMS
Novartis Pharmaceuticals Corporation $83.3308/23/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086786737 CMS
Acrotech Biopharma Inc. $22.2008/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147104866 CMS
Lilly USA, LLC $15.9008/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135354778 CMS
Janssen Biotech, Inc. $18.4408/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078745629 CMS
ARRAY BIOPHARMA INC $14.2108/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131900301 CMS
Merck Sharp & Dohme LLC $24.2408/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141778225 CMS
Novartis Pharmaceuticals Corporation $22.7408/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086786731 CMS
ARRAY BIOPHARMA INC $7.3508/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131367123 CMS
Deciphera Pharmaceuticals Inc. $20.6808/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145872879 CMS
SpringWorks Therapeutics, Inc. $18.7008/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1085803790 CMS
Regeneron Healthcare Solutions, Inc. $28.6308/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114032978 CMS
GlaxoSmithKline, LLC. $16.7308/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116571673 CMS
Eisai Inc. $19.1308/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110776617 CMS
Eisai Inc. $3.3608/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110776619 CMS
Novartis Pharmaceuticals Corporation $24.6908/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086786723 CMS
SERVIER PHARMACEUTICALS LLC $21.1708/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147263011 CMS
TAIHO ONCOLOGY, INC. $27.3508/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1137935113 CMS
Novartis Pharmaceuticals Corporation $19.7508/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086786725 CMS
Collegium Pharmaceutical, Inc. $14.3908/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135284003 CMS
Genentech USA, Inc. $20.1708/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133097471 CMS
PUMA BIOTECHNOLOGY, INC. $15.3807/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1113856044 CMS
Tempus AI, Inc $13.0307/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150163314 CMS
JAZZ PHARMACEUTICALS INC. $27.1607/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1150229267 CMS
Janssen Biotech, Inc. $20.1107/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078745933 CMS
Incyte Corporation $14.5807/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141173405 CMS
Astellas Pharma US Inc $6.4107/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139392610 CMS
Eisai Inc. $25.7107/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1110776629 CMS
Astellas Pharma US Inc $8.3707/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139392586 CMS
Gilead Sciences, Inc. $16.5707/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133800156 CMS
Genentech USA, Inc. $23.2207/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133097439 CMS
PFIZER INC. $17.3807/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131795962 CMS
SOBI, INC $22.0707/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141432127 CMS
GlaxoSmithKline, LLC. $4.2307/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1115985392 CMS
Genentech USA, Inc. $23.4907/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1133097492 CMS
Novartis Pharmaceuticals Corporation $1.8007/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086786727 CMS
Novartis Pharmaceuticals Corporation $23.5007/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086786729 CMS
Ipsen Biopharmaceuticals, Inc $23.0007/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1091960139 CMS
Stemline Therapeutics Inc. $21.5807/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1142963506 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,056.84 260
PY2020 $4,700.62 195
PY2021 $6,170.05 280
PY2022 $6,144.51 314
PY2023 $6,346.28 281
PY2024 $7,804.76 311
PY2025 $7,260.27 323

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $435.09 1
PY2022 Principal investigator $149.79 1
PY2021 Principal investigator $3,049.87 2
PY2020 Principal investigator $660.00 10
PY2019 Principal investigator $1,451.50 18

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

1 record in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $435.09 12/31/2023 Non-covered Recipient Entity
Genesys Regional Medical Center
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 1042496261